Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498533 | PMC |
http://dx.doi.org/10.3389/fvets.2020.00595 | DOI Listing |
Rev Clin Esp (Barc)
November 2024
Unit of Lipids and vascular Risk, Hospital del Mar, Barcelona, Spain.
Introduction: There are very few studies evaluating lipid-lowering treatments (LLTs) and low-density lipoprotein-cholesterol (LDL-C) goal attainment after the release of the 2019 guidelines of the European Societies of Cardiology (ESC) and Atherosclerosis (EAS). This manuscript shows baseline data of the Spanish subset from SANTORINI study (namely SANTORINI Spain) on LDL-C goal attainment and use of LLTs in patients at high and very high cardiovascular risk.
Methods: SANTORINI was a multinational, prospective, observational study involving patients at high and very high cardiovascular risk from 14 European countries in primary care and specialized healthcare settings.
Front Physiol
November 2024
School of Control Science and Engineering, Shandong University, Jinan, China.
Background: Stroke is one of the major chronic non-communicable diseases (NCDs) with high morbidity, disability and mortality. The key to preventing stroke lies in controlling risk factors. However, screening risk factors and quantifying stroke risk levels remain challenging.
View Article and Find Full Text PDFInt J Clin Pharm
November 2024
College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Cancer
October 2024
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
NEJM Evid
November 2024
State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Sir Yue-Kong Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!